Rahsaan Thompson, Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 42,666 shares at $11.13 ($475K) on 2026-08-14, disclosed to the SEC on 2026-08-17.
Scheduled sale ($475k) by Chief Legal & Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZVRA | SELL | 2026-02-02 | $72K | — | Filing → |
| ZVRA | SELL | 2025-06-30 | $442K | — | Filing → |